Working… Menu

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04526990
Recruitment Status : Recruiting
First Posted : August 26, 2020
Last Update Posted : January 22, 2021
Beijing Institute of Biotechnology
Information provided by (Responsible Party):
CanSino Biologics Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2021
Estimated Study Completion Date : January 30, 2022